
HPV vaccination and lifestyle changes may curb rising head and neck cancers
Head and neck cancers, especially oral cavity and pharynx, are rising in the U.S. and globally, with HPV now a leading risk factor. Prevention centers on HPV vaccination (two doses at 11–12 years, can start 9–26, approved up to 45) and lifestyle changes such as quitting smoking and reducing alcohol use, which substantially lower risk. There is no broad screening, and five-year survival is about 70%.













